Successful treatment with azathioprine of relapsing Rosai-Dorfman disease of the central nervous system: Case report

Journal of Neurosurgery

Volumn 117, Issue 3, 2012, Pages 486-489

  Le Guenno, Guillaume ^a   Galicier, Lionel ^b   Uro Coste, Emmanuelle ^c   Petitcolin, Virginie ^d   Rieu, Virginie ^a   Ruivard, Marc ^a  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c CHU RANGUEIL   (France)

^d University Estaing   (France)

Author keywords

Azathioprine; Crohn disease; Meningioma; Oncology; Rosai Dorfman disease; Sinus histiocytosis

Indexed keywords

AZATHIOPRINE; BUDESONIDE; CLOBAZAM; DOXYCYCLINE; ETIRACETAM; HYDROXYCHLOROQUINE; OXCARBAZEPINE;

ADULT; ARTICLE; ATAXIC APHASIA; AUDITORY HALLUCINATION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; DRUG DOSE REDUCTION; FOCAL EPILEPSY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; PERICARDITIS; PRIORITY JOURNAL; Q FEVER; ROSAI DORFMAN DISEASE; TEMPORAL LOBE EPILEPSY;

AZATHIOPRINE; CENTRAL NERVOUS SYSTEM DISEASES; COMORBIDITY; CROHN DISEASE; FOLLOW-UP STUDIES; HISTIOCYTOSIS, SINUS; HUMANS; ILEITIS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RECURRENCE; REMISSION INDUCTION; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84865851344     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2012.5.JNS12148     Document Type: Article

References (15)

1. Adeleye AO, Amir G, Fraifeld S, Shoshan Y, Umansky F, Spektor S: Diagnosis and management of Rosai-Dorfman disease involving the central nervous system. Neurol Res 32:572-578, 2010
2. Ahmed F, Jacobson IM, Herrera JL, Brand M, Wasserman RB, Fixelle AM, et al: Seizures during pegylated interferon and ribavirin therapy for chronic Hepatitis C: observations from the WIN-R trial. J Clin Gastroenterol 45:286-292, 2011
3. Benoit M, Barbarat B, Bernard A, Olive D, Mege JL: Coxiella burnetii, the agent of Q fever, stimulates an atypical M2 activation program in human macrophages. Eur J Immunol 38:1065-1070, 2008
4. Burger D, Travis S: Conventional medical management of inflammatory bowel disease. Gastroenterology 140:1827-1837, 2011
5. Casanova JL, Abel L: Revisiting Crohn's disease as a primary immunodeficiency of macrophages. J Exp Med 206:1839-1843, 2009
6. Foucar E, Rosai J, Dorfman R: Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity. Semin Diagn Pathol 7:19-73, 1990 (Pubitemid 20075700)
7. Horneff G, Jürgens H, Hort W, Karitzky D, Göbel U: Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): response to methotrexate and mercaptopurine. Med Pediatr Oncol 27:187-192, 1996
8. Huang HY, Huang CC, Lui CC, Chen HJ, Chen WJ: Isolated intracranial Rosai-Dorfman disease: case report and literature review. Pathol Int 48:396-402, 1998
9. Jabali Y, Smrcka V, Pradna J: Rosai-Dorfman disease: successful long-term results by combination chemotherapy with prednisone, 6-mercaptopurine, methotrexate, and vinblastine: a case report. Int J Surg Pathol 13:285-289, 2005 (Pubitemid 41117506)
10. Jadus MR, Sekhon S, Barton BE, Wepsic HT: Macrophage colony stimulatory factor-activated bone marrow macrophages suppress lymphocytic responses through phagocytosis: a tentative in vitro model of Rosai-Dorfman disease. J Leukoc Biol 57:936-942, 1995
11. Le Guenno G, Galicier L, Fieschi C, Meignin V, Chabrol A, Oksenhendler E: Dramatic efficiency of pegylated interferon in sinus histiocytosis with massive lymphadenopathy. Br J Dermatol 164:213-215, 2011
12. Potts CA, Bozeman AP, Walker AN, Floyd WE III: Cutaneous Rosai-Dorfman disease of the forearm: case report. J Hand Surg Am 33:1409-1413, 2008
13. Pulsoni A, Anghel G, Falcucci P, Matera R, Pescarmona E, Ribersani M, et al: Treatment of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): report of a case and literature review. Am J Hematol 69:67-71, 2002
14. Scherzer TM, Staufer K, Novacek G, Steindl-Munda P, Schumacher S, Hofer H, et al: Efficacy and safety of antiviral therapy in patients with Crohn's disease and chronic hepatitis C. Aliment Pharmacol Ther 28:742-748, 2008
15. Zhu H, Qiu LH, Dou YF, Wu JS, Zhong P, Jiang CC, et al: Imaging characteristics of Rosai-Dorfman disease in the central nervous system. Eur J Radiol 81:1265-1272, 2012